XML 50 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill and Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of acquired intangible assets
Other intangible assets are amortized in equal installments over their estimated useful lives as follows:
Intangible AssetAmortization Period
Option over non-financial assetsOver the period of the relevant agreement
Components of the Company's acquired intangible assets are comprised of the following:

December 31, 2021
GrossAccumulated amortization and impairment chargesNet
Utrophin program acquired$4,487 $(4,487)$— 
Discuva platform acquired14,416 (4,017)10,399 
Option over non-financial asset912 (912)— 
Other patents and licenses148 (148)— 
$19,963 $(9,564)$10,399 
December 31, 2020
GrossAccumulated amortization and impairment chargesNet
Utrophin program acquired$4,534 $(4,534)$— 
Discuva platform acquired14,565 (3,050)11,515 
Option over non-financial asset(1)
921 (921)— 
Other patents and licenses150 (150)— 
$20,170 $(8,655)$11,515 

(1)During the year ended December 31, 2020, management identified an impairment related to the option over non-financial asset pursuant to an Evaluation and Option Agreement with a collaboration partner. The partner is no longer conducting antibiotic candidate programs over which the Company had the option, management therefore determined that the fair value of the option to acquire the assignment of the proprietary rights for antibiotic candidates is $0. Accordingly, the asset was written off in its entirety resulting in an impairment charge of $859 recognized in operating expenses.
Schedule estimated future amortization expense related to acquired intangible assets
The estimated net amortization expense related to acquired intangible assets for future years is:

Amount
2022$999 
2023$999 
2024$999 
2025$999 
2026$999 
Thereafter$5,404